Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the …
Gusto V Investigators - The Lancet, 2001 - Elsevier
BACKGROUND: Plasminogen activator therapy for acute myocardial infarction is limited by
lack of achievement of early, complete, and sustained reperfusion in a substantial proportion …
lack of achievement of early, complete, and sustained reperfusion in a substantial proportion …
[引用][C] Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition …
FWA VERHEUGT - Lancet (British edition), 2001 - pascal-francis.inist.fr
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination
reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V …
reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V …
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the …
EJ Topol… - Lancet (London …, 2001 - pubmed.ncbi.nlm.nih.gov
Background Plasminogen activator therapy for acute myocardial infarction is limited by lack
of achievement of early, complete, and sustained reperfusion in a substantial proportion of …
of achievement of early, complete, and sustained reperfusion in a substantial proportion of …
[引用][C] Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition …
EJ Topol, AM Lincoff, RM Califf, EM Ohman, E Bates… - The Lancet, 2001 - swepub.kb.se
SwePub - Reperfusion therapy for acute... ↓ Direkt till sidans innehåll ↓ Direkt till sidans
sekundära innehåll (sidomenyn) SwePub Om SwePub In English Sökhistorik/mina poster Rensa …
sekundära innehåll (sidomenyn) SwePub Om SwePub In English Sökhistorik/mina poster Rensa …
[引用][C] Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition …
GUSTO V Investigators - The Lancet, 2001 - cir.nii.ac.jp
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination
reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V …
reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V …
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the …
E Topol, R Califf, F Van de Werf, J Willerson, J Booth… - THE LANCET, 2001 - air.unipr.it
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination
reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO randomised …
reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO randomised …
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the …
EJ Topol - Lancet (London, England), 2001 - europepmc.org
Background Plasminogen activator therapy for acute myocardial infarction is limited by lack
of achievement of early, complete, and sustained reperfusion in a substantial proportion of …
of achievement of early, complete, and sustained reperfusion in a substantial proportion of …
[引用][C] Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition …
EJ Topol, AM Lincoff, RM Califf, EM Ohman, E Bates… - The Lancet, 2001 - diva-portal.org